CienciaySaludNatural.com
El público está en alerta por miocarditis, coágulos sanguíneos y daños neurológicos con la vacunación contra el COVID-19, pero ahora también se habla de nuevas erupciones cutáneas. Un artículo de Seirafianpour et al resumió 180 artículos/informes impresionantes de los primeros siete meses de la campaña de vacunación solamente, describiendo en tablas exhaustivas la amplia gama de erupciones cutáneas y trastornos de las superficies mucosas (boca/nariz/ano) donde la proteína pico, o Spike de la inyección y/o los mediadores inflamatorios provocan manifestaciones dermatológicas. Nunca ha habido una inyección que tenga este grado de toxicidad dermatológica grave y bien documentada.
Al final del artículo hemos incluido 480 estudios más, revisados por pares sobre efectos adversos de la Inyección K0 B1T en la piel
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111423/pdf/DTH-35-0.pdf
Seirafianpour F, Pourriyahi H, Gholizadeh Mesgarha M, Pour Mohammad A, Shaka Z, Goodarzi A. A systematic review on mucocutaneous presentations after COVID-19 vaccination and expert recommendations about vaccination of important immune-mediated dermatologic disorders. Dermatol Ther. 2022 Jun;35(6):e15461. doi: 10.1111/dth.15461. Epub 2022 Apr 11. PMID: 35316551; PMCID: PMC9111423.Seirafianpour F, Pourriyahi H, Gholizadeh Mesgarha M, Pour Mohammad A, Shaka Z, Goodarzi A. Una revisión sistemática sobre presentaciones mucocutáneas después de la vacunación contra el COVID-19 y recomendaciones de expertos sobre la vacunación de importantes trastornos dermatológicos inmunomediados. Dermatol Ther. 2022 junio;35(6):e15461. doi: 10.1111/dth.15461. Epub 2022 11 de abril. PMID: 35316551; PMCID: PMC9111423.
Uno de los principales hallazgos de los autores es: “Los efectos secundarios se informaron con mayor frecuencia dentro de los primeros 3 días después de la vacunación, pero también hubo algunos estudios que informaron reacciones adversas tardías, hasta 4 semanas después de la vacunación.
La duración de las reacciones varió desde casi 1 día con mayor frecuencia hasta 4 semanas o más. La localización más frecuente de las lesiones mucocutáneas fue en miembros superiores (lugar de inyección), tronco y cara.
Casi la mitad de estos estudios informaron las comorbilidades de los participantes. Las comorbilidades más comúnmente reportadas fueron:
- hipertensión,
- antecedentes de COVID-19,
- diabetes mellitus,
- trastornos cardiovasculares,
- autoinmunes,
- reumatológicos o
- alérgicos,
- neoplasias malignas,
- obesidad y
- anafilaxia”.
https://openvaers.com/covid-data/shingles
Este estudio deja en claro que si uno tiene un trastorno autoinmune o alérgico al inicio, entonces una inyección COVID-19 está causando un gran problema. Otras condiciones enumeradas deberían servir como advertencias similares.
Muchas de estas erupciones son duraderas, requerirán citas dermatológicas y, en algunos casos, necesitarán infusiones intravenosas intermitentes y costosas. Se ha recomendado que las inyecciones se retiren del mercado y en este momento no se pueden recomendar a nadie.
Si encuentra “ este artículo útil suscríbase como miembro de nuestro equipo para apoyarnos y en conjunto podamos aclarar el tema en discusiones con familiares, amigos, funcionarios y empleadores. La experiencia nos dice que cuando la gente esta siendo coaccionada y no entiende que pasa, cuando finalmente se enteran quien y como los están coaccionando, entonces pueden salir de la confusión, eliminar el miedo y actuar seguros para defenderse. Para lograr esto primero hace falta informar con evidencia de primera línea, no de forma periodística sino con una base de datos con la documentación científica de expertos, libre de conflictos de intereses. Para llevar a cabo esta base de datos en cienciaysaludnatural.com hace falta recursos, pagar hosting y tiempo de elaboración de contenidos. Necesitamos que las personas que reconocen el valor del proyecto nos recomienden para poder continuarlo. Muchas gracias. Puede Apoyarnos en https://cienciaysaludnatural.com/colaboracion
Colabore con nosotros para que podamos llegar a más personas: contribución en mercado pago o paypal por única vez:
7.000$ http://mpago.la/1vntd29
3.000$ https://mpago.la/2qphKTN
1.000$ https://mpago.la/1Q1NEKM
500 $ https://mpago.la/2u2cZrG
Via Paypal: Euros o dólares click aqui
Solicite nuestro CBU contactenos
480 Estudios más sobre efectos adversos de la Inyección K0 B1T en la piel
| https://pubmed.ncbi.nlm.nih.gov/34742927/ | A localised vasculitic-like skin rash following the second dose of COVID-19 vaccine – PubMed | Abobaker et al |
| https://pubmed.ncbi.nlm.nih.gov/33783017/ | Persistent maculopapular rash after the first dose of Pfizer-BioNTech COVID-19 vaccine | Ackerman et al |
| https://pubmed.ncbi.nlm.nih.gov/34686374/ | Bullous pemphigoid induced by the AstraZeneca COVID-19 vaccine | Agharbi et al |
| https://pubmed.ncbi.nlm.nih.gov/35218057/ | Cutaneous reactions after coronavirus disease 2019 vaccination: Summary of 20 Japanese cases | Akatsuka et al |
| https://pubmed.ncbi.nlm.nih.gov/35187768/ | Pemphigus vulgaris after SARS-CoV-2 vaccination: A case with new-onset and two cases with severe aggravation | Akoglu |
| https://pubmed.ncbi.nlm.nih.gov/34236714/ | Vitiligo in a COVID-19-vaccinated patient with ulcerative colitis: coincidence? | Aktas & Ertuğrul |
| https://pubmed.ncbi.nlm.nih.gov/35371700/ | Generalized Papulovesicular Eruption as a Side Effect of the Pfizer-BioNTech COVID-19 Vaccine | Alamri et al |
| https://pubmed.ncbi.nlm.nih.gov/34391695/ | Palms and soles itchiness as a side effect of COVID-19 vaccination | Al-Ansari et al |
| https://pubmed.ncbi.nlm.nih.gov/35386174/ | Lichen Planus Eruption Following Oxford-AstraZeneca COVID-19 Vaccine Administration: A Case Report and Review of Literature | Alrawashdeh et al |
| https://pubmed.ncbi.nlm.nih.gov/35251600/ | Bullous pemphigoid after second dose of mRNA- (Pfizer-BioNTech) Covid-19 vaccine: A case report – PubMed | Alshammari et al |
| https://pubmed.ncbi.nlm.nih.gov/35422564/ | Atypical Presentation of Erythema Nodosum Following Pfizer-BioNTech COVID-19 Vaccine | Alzoabi et al |
| https://pubmed.ncbi.nlm.nih.gov/34545609/ | Skin ulcer at the injection site of BNT162b2 mRNA COVID-19 vaccine | Aoki et al |
| https://pubmed.ncbi.nlm.nih.gov/35449768/ | Morphea in two patients after being infected to and being vaccinated against SARS-CoV-2 infection | Aryanian et al (1) |
| https://pubmed.ncbi.nlm.nih.gov/34791786/ | Pigmented purpuric dermatosis after BNT162B2 mRNA COVID-19 vaccine administration | Atak et al |
| https://pubmed.ncbi.nlm.nih.gov/35067994/ | Reply to ‘The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated?’ by Damiani G et al | Avallone et al |
| https://pubmed.ncbi.nlm.nih.gov/34997985/ | Inverse lichen planus post Oxford-AstraZeneca COVID-19 vaccine | Awada et al |
| https://pubmed.ncbi.nlm.nih.gov/34835143/ | Sweet Syndrome Following SARS-CoV2 Vaccination | Baffa et al (1) |
| https://pubmed.ncbi.nlm.nih.gov/35308065/ | A case report of anti-P200 pemphigoid following COVID-19 vaccination | Bailly-Caillé et al |
| https://pubmed.ncbi.nlm.nih.gov/34748655/ | Phenotypic spectrum of serious cutaneous-only adverse event following immunization with COVID-19 vaccines: a multicentre case series and literature review | Balogun et al |
| https://pubmed.ncbi.nlm.nih.gov/35062748/ | Pyoderma Gangrenosum Induced by BNT162b2 COVID-19 Vaccine in a Healthy Adult | Barry et al |
| https://pubmed.ncbi.nlm.nih.gov/34272069/ | [Eczematiform eruption after Pfizer-BioNTech COVID-19 vaccine] | Bekkali et al |
| https://pubmed.ncbi.nlm.nih.gov/34423105/ | Lichen striatus post-COVID-19 vaccination | Belina et al |
| https://pubmed.ncbi.nlm.nih.gov/35288926/ | SARS-CoV-2 vaccine induced Sweet syndrome : a case report | Ben Rejeb et al |
| https://pubmed.ncbi.nlm.nih.gov/34473839/ | Atypical erythema multiforme related to BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine | Bonino et al |
| https://pubmed.ncbi.nlm.nih.gov/34547125/ | Pfizer-BioNTech SARS-CoV-2 mRNA vaccine-associated erythema multiforme | Borg et al |
| https://pubmed.ncbi.nlm.nih.gov/34606671/ | Pfizer/BioNTech-associated perniosis in two young adults with re-challenge evidence | Brooks SG et al |
| https://pubmed.ncbi.nlm.nih.gov/35224170/ | New-onset of vitiligo in a child following COVID-19 vaccination | Bukhari |
| https://pubmed.ncbi.nlm.nih.gov/35148438/ | Reply to «COVID vaccine-induced lichen planus on areas previously affected by vitiligo» | Bularca et al |
| https://pubmed.ncbi.nlm.nih.gov/34837354/ | Cutaneous reactions to COVID-19 vaccine at the dermatology primary care | Burlando et al |
| https://pubmed.ncbi.nlm.nih.gov/34902185/ | Reply to ‘New-onset cutaneous lichen planus triggered by COVID-19 vaccination’ by Merhy et al | Camela et al |
| https://pubmed.ncbi.nlm.nih.gov/34236735/ | Pernio-like skin lesions after the second dose of Pfizer-BioNTech COVID-19 vaccine | Cameli et al (1) |
| https://pubmed.ncbi.nlm.nih.gov/34214206/ | AstraZeneca (AZD1222) COVID-19 vaccine-associated adverse drug event: A case report | Capassoni et al |
| https://pubmed.ncbi.nlm.nih.gov/35266259/ | Vitiligo worsened following the second dose of mRNA SARS-CoV-2 vaccine | Caroppo et al |
| https://pubmed.ncbi.nlm.nih.gov/34254291/ | Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases | Català et al |
| https://pubmed.ncbi.nlm.nih.gov/35455281/ | Development of Flat Warts on the Cheeks after BioNTech-Pfizer BNT162b2 Vaccine: Is There a Correlation? | Cazzato et al (1) |
| https://pubmed.ncbi.nlm.nih.gov/35434826/ | Erythema nodosum induced by Covid-19 Pfizer-BioNTech mRNA vaccine: A case report and brief literature review | Chahed et al |
| https://pubmed.ncbi.nlm.nih.gov/34751491/ | Sudden onset of vitiligo after COVID-19 vaccine | Ciccarese et al (1) |
| https://pubmed.ncbi.nlm.nih.gov/35247654/ | Diffuse cutaneous systemic sclerosis following SARS-Co V-2 vaccination | Cole et al |
| https://pubmed.ncbi.nlm.nih.gov/34557622/ | Cutaneous vasculitis after severe acute respiratory syndrome coronavirus 2 vaccine | Colia et al |
| https://pubmed.ncbi.nlm.nih.gov/33834563/ | Transient cutaneous manifestations after administration of Pfizer-BioNTech COVID-19 Vaccine: an Italian single-centre case series | Corbeddu et al |
| https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8444733/ | Vesiculobullous skin reactions induced by COVID‐19 mRNA vaccine: report of four cases and review of the literature – PMC | Coto‐Segura et al |
| https://pubmed.ncbi.nlm.nih.gov/33982814/ | Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine | Cyrenn et al |
| https://pubmed.ncbi.nlm.nih.gov/34169578/ | The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated? | Damiani et al |
| https://pubmed.ncbi.nlm.nih.gov/33620081/ | ‘Blue toes’ following vaccination with the BNT162b2 mRNA COVID-19 vaccine | Davido et al |
| https://pubmed.ncbi.nlm.nih.gov/34854640/ | [A red and swollen arm after vaccination for covid-19] | De Mik et al |
| https://pubmed.ncbi.nlm.nih.gov/34786801/ | Bullous pemphigoid triggered by COVID-19 vaccine: Rapid resolution with corticosteroid therapy | Dell’Antonia et al |
| https://pubmed.ncbi.nlm.nih.gov/34730195/ | Acute tubulointerstitial nephritis after COVID-19 m-RNA BNT162b2 vaccine | Dheir et al |
| https://pubmed.ncbi.nlm.nih.gov/34953018/ | Lichen planus and lichen planopilaris flare after COVID-19 vaccination | Diab et al |
| https://www.mdpi.com/2076-393X/10/4/602 | Delayed Cutaneous Adverse Reaction of the AstraZeneca COVID-19 Vaccine in a Breastfed Female Infant: A Coincidence or a Rare Effect? (Breastfeeding Infant AE) Vaccines | Free Full-Text | | Diogo et al |
| https://pubmed.ncbi.nlm.nih.gov/35199304/ | Persistent pruritus following COVID-19 vaccination | Doyle & Watchorn |
| https://pubmed.ncbi.nlm.nih.gov/35237629/ | Case Report: Rowell Syndrome-Like Flare of Cutaneous Lupus Erythematosus Following COVID-19 Infection | Drenovska et al |
| https://pubmed.ncbi.nlm.nih.gov/35133700/ | Erythroderma related with the first dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine in a patient with psoriasis | Durmus et al |
| https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8447368/ | Widespread purpura annularis telangiectodes following mRNA SARS‐CoV‐2 vaccine – PMC | Falkenhain‐López et al |
| https://pubmed.ncbi.nlm.nih.gov/35211310/ | De novo and relapsing necrotizing vasculitis after COVID-19 vaccination | Fillon et al |
| https://pubmed.ncbi.nlm.nih.gov/33725406/ | Prompt onset of Rowell’s syndrome following the first BNT162b2 SARS-CoV-2 vaccination | Gambichler et al (1) |
| https://pubmed.ncbi.nlm.nih.gov/35132838/ | Dermatomyositis Following BNT162b2 mRNA COVID-19 Vaccination | Gouda et al |
| https://pubmed.ncbi.nlm.nih.gov/34416053/ | ‘COVID vaccine arm’ may present after both mRNA vaccines vaccination | Gregoriou et al |
| https://pubmed.ncbi.nlm.nih.gov/34585371/ | A case of COVID-19 vaccination-associated forme fruste purpura fulminans | Griss et al |
| https://pubmed.ncbi.nlm.nih.gov/33982318/ | Recurrent injection‐site reactions after incorrect subcutaneous administration of a COVID‐19 vaccine | Gyldenløve et al |
| https://pubmed.ncbi.nlm.nih.gov/34762342/ | Linear IgA bullous dermatosis following Oxford AstraZeneca COVID-19 vaccine | Hali F et al |
| https://pubmed.ncbi.nlm.nih.gov/35425676/ | Autoimmune Bullous Dermatosis Following COVID-19 Vaccination: A Series of Five Cases | Hali Sr ete al |
| https://pubmed.ncbi.nlm.nih.gov/35571457/ | Toxic epidermal necrolysis-like linear IgA bullous dermatosis after third Moderna COVID-19 vaccine in the setting of oral terbinafine | Han J et al |
| https://pubmed.ncbi.nlm.nih.gov/34934493/ | Lichen planus flare following COVID-19 vaccination: A case report | Herzum et al |
| https://pubmed.ncbi.nlm.nih.gov/33724563/ | Lichen planus arising after COVID-19 vaccination | Hiltun et al |
| https://pubmed.ncbi.nlm.nih.gov/34423106/ | A case series of cutaneous COVID-19 vaccine reactions at Loma Linda University Department of Dermatology – PubMed | Holmes et al |
| https://pubmed.ncbi.nlm.nih.gov/34379821/ | Pityriasis rubra pilaris-like eruption following administration of the BNT163b2 (Pfizer-BioNTech) mRNA COVID-19 vaccine | Hunjan et al |
| https://pubmed.ncbi.nlm.nih.gov/35293793/ | Leukocytoclastic Vasculitic Rash Following Second Dose of Moderna COVID-19 Vaccine | Ireifej et al |
| https://pubmed.ncbi.nlm.nih.gov/34513435/ | Petechiae and Desquamation of Fingers Following Immunization With BTN162b2 Messenger RNA (mRNA) COVID-19 Vaccine – PubMed | Irvine & Wiles |
| https://pubmed.ncbi.nlm.nih.gov/34546346/ | Non-episodic angioedema with eosinophilia after BNT162b2 mRNA COVID-19 vaccination | Ishizuka et al |
| https://pubmed.ncbi.nlm.nih.gov/33560802/ | Morbilliform rash after administration of Pfizer-BioNTech COVID-19 mRNA vaccine | Jedlowski & Jedlowski |
| https://pubmed.ncbi.nlm.nih.gov/33978670/ | Delayed Localized Hypersensitivity Reactions to the Moderna COVID-19 Vaccine: A Case Series | Johnston et al |
| https://pubmed.ncbi.nlm.nih.gov/34455671/ | Subacute cutaneous lupus erythematosus flare triggered by COVID-19 vaccine | Joseph & Chong |
| https://pubmed.ncbi.nlm.nih.gov/34603727/ | New-onset vitiligo following mRNA-1273 (Moderna) COVID-19 vaccination – PubMed | Kaminetzky & Rudikoff |
| https://pubmed.ncbi.nlm.nih.gov/35263820/ | Oral lichen planus following mRNA COVID-19 vaccination | Kaomongkolgit & Sawangarun |
| https://pubmed.ncbi.nlm.nih.gov/34162525/ | «COVID Toes» After mRNA COVID-19 Vaccines | Kelso et al |
| https://pubmed.ncbi.nlm.nih.gov/34242422/ | ‘COVID arm’ – histological features of a delayed-type hypersensitivity reaction to Moderna mRNA-1273 SARS-CoV2 vaccine | Kempf et al |
| https://pubmed.ncbi.nlm.nih.gov/34423142/ | Moderna COVID-19 vaccine induced skin rash – PMC | Khalid et al |
| https://pubmed.ncbi.nlm.nih.gov/34751429/ | A case of toxic epidermal necrolysis after ChAdOx1 nCov‐19 (AZD1222) vaccination – PMC | Kherlopian et al |
| https://pubmed.ncbi.nlm.nih.gov/34661942/ | Generalized erythema multiforme-like skin rash following the first dose of COVID-19 vaccine (Pfizer-BioNTech) | Kim MJ et al |
| https://pubmed.ncbi.nlm.nih.gov/35357514/ | [Delayed local reaction with subcutaneous infiltration after vaccination with mRNA-1273-a previously undescribed reaction pattern of COVID arm] | Kofler & Forchhammer |
| https://pubmed.ncbi.nlm.nih.gov/34294590/ | Bullous drug eruption after second dose of mRNA-1273 (Moderna) COVID-19 vaccine: Case report – PubMed | Kong et al |
| https://pubmed.ncbi.nlm.nih.gov/34131967/ | Psoriasis flare-up associated with second dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine | Krajewski et al |
| https://pubmed.ncbi.nlm.nih.gov/34291477/ | Induction and exacerbation of subacute cutaneous lupus erythematosus following mRNA-based or adenoviral vector-based SARS-CoV-2 vaccination | Kreuter et al |
| https://pubmed.ncbi.nlm.nih.gov/34292611/ | Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination | Larson et al |
| https://pubmed.ncbi.nlm.nih.gov/33914926/ | A flare of pre-existing erythema multiforme following BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine | Lavery et al |
| https://pubmed.ncbi.nlm.nih.gov/34557507/ | Case Report: Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination – PubMed | Leerunyakul et al |
| https://pubmed.ncbi.nlm.nih.gov/34131969/ | Chilblain-like lesions after BNT162b2 mRNA COVID-19 vaccine: a case report suggesting that ‘COVID toes’ are due to the immune reaction to SARS-CoV-2 | Lesort et al |
| https://pubmed.ncbi.nlm.nih.gov/34120504/ | COVID Arm: Delayed Hypersensitivity Reactions to SARS-CoV-2 Vaccines Misdiagnosed as Cellulitis | Lindgren et al |
| https://pubmed.ncbi.nlm.nih.gov/35130405/ | New-onset cutaneous lupus erythematosus after the COVID-19 vaccine | Liu & Messenger |
| https://pubmed.ncbi.nlm.nih.gov/33893637/ | Pernio after COVID-19 vaccination | Lopez S et al |
| https://pubmed.ncbi.nlm.nih.gov/33855706/ | Cutaneous reaction to BNT162b2 mRNA COVID-19 vaccine | López-Valle et al |
| https://pubmed.ncbi.nlm.nih.gov/34590397/ | Sweet syndrome after Oxford-AstraZeneca COVID-19 vaccine (AZD1222) in an elderly female – PubMed | Majid & Mearaj |
| https://pubmed.ncbi.nlm.nih.gov/35356381/ | Woman with pruritic rash and dermatographism | Malcolm & Shah |
| https://pubmed.ncbi.nlm.nih.gov/35295599/ | Bullous Pemphigoid Associated With COVID-19 Vaccines: An Italian Multicentre Study | Maronese et al |
| https://pubmed.ncbi.nlm.nih.gov/34936145/ | Extensive cutaneous lichen planus triggered by viral vector COVID-19 vaccination (ChAdOx1 nCoV-19) | Masseran et al |
| https://pubmed.ncbi.nlm.nih.gov/34048614/ | Purpuric lesions on the eyelids developed after BNT162b2 mRNA COVID-19 vaccine: another piece of SARS-CoV-2 skin puzzle? | Mazzatenta et al |
| https://pubmed.ncbi.nlm.nih.gov/34210829/ | A Case of Chilblains-like Lesions Post SARS-CoV-2 Vaccine? | Meara et al |
| https://pubmed.ncbi.nlm.nih.gov/34236718/ | New-onset cutaneous lichen planus triggered by COVID-19 vaccination | Merhy et al |
| https://pubmed.ncbi.nlm.nih.gov/34319363/ | Association of Facial Pustular Neutrophilic Eruption With Messenger RNA-1273 SARS-CoV-2 Vaccine | Merrill et al |
| https://pubmed.ncbi.nlm.nih.gov/35145806/ | Vitiligo Possibly Triggered by COVID-19 Vaccination | Militello et al |
| https://pubmed.ncbi.nlm.nih.gov/35536295/ | Development of delayed dermal hypersensitivity reaction following the second dose of COVID-19 vaccine – A series of 37 cases | Mohta & Sharma |
| https://pubmed.ncbi.nlm.nih.gov/34547138/ | Eosinophilic cellulitis after BNT162b2 mRNA Covid-19 vaccine | Montjoye et al |
| https://pubmed.ncbi.nlm.nih.gov/33559733/ | «COVID-19/SARS-CoV-2 virus spike protein-related delayed inflammatory reaction to hyaluronic acid dermal fillers: a challenging clinical conundrum in diagnosis and treatment» | Munavalli et al (1) |
| https://pubmed.ncbi.nlm.nih.gov/34676639/ | Generalized dermal hypersensitivity reaction following Moderna COVID-19 vaccination | Myrdal et al |
| https://pubmed.ncbi.nlm.nih.gov/34545973/ | Case of bullous pemphigoid following coronavirus disease 2019 vaccination | Nakamura et al |
| https://pubmed.ncbi.nlm.nih.gov/35137500/ | Figurate purpuric eruption post-COVID-19 vaccination | Namazi et al |
| https://pubmed.ncbi.nlm.nih.gov/34075664/ | Exacerbation of subacute cutaneous lupus erythematosus following vaccination with BNT162b2 mRNA vaccine | Niebel et al (1) |
| https://pubmed.ncbi.nlm.nih.gov/34167874/ | Clinical and histopathological views of morbilliform rash after COVID-19 mRNA vaccination mimic those in SARS-CoV-2 virus infection-associated cutaneous manifestations | Ohsawa et al |
| https://pubmed.ncbi.nlm.nih.gov/34931408/ | Worsening of the vitiligo following the second dose of the BNT162B2 mRNA COVID-19 vaccine | Okan & Vural |
| https://pubmed.ncbi.nlm.nih.gov/35455266/ | Frequent Onsets of Cellulitis in Lower Limbs with Lymphedema Following COVID-19 mRNA Vaccination | Okazaki et al |
| https://pubmed.ncbi.nlm.nih.gov/35169602/ | Severe flare of pemphigus vulgaris after first dose of COVID-19 vaccine | Ong et al |
| https://pubmed.ncbi.nlm.nih.gov/34631106/ | Lichenoid cutaneous skin eruption and associated systemic inflammatory response following Pfizer-BioNTech mRNA COVID-19 vaccine administration | Onn & Chang |
| https://pubmed.ncbi.nlm.nih.gov/35097176/ | Palmoplantar lichenoid drug eruption following the administration of Pfizer-BioNTech COVID-19 vaccine | Paolino & Rongioletti |
| https://pubmed.ncbi.nlm.nih.gov/35224780/ | Generalized pustular psoriasis flare in a patient affected by plaque psoriasis after BNT162b2 mRNA COVID-19 vaccine, successfully treated with risankizumab | Pavia et al |
| https://pubmed.ncbi.nlm.nih.gov/34533265/ | Pityriasis rosea-like cutaneous eruption as a possible dermatological manifestation after Oxford-AstraZeneca vaccine: Case report and brief literature review | Pedrazini & da Silva |
| https://pubmed.ncbi.nlm.nih.gov/34119340/ | Bullous pemphigoid and COVID-19 vaccine | Pérez-López et al (1) |
| https://pubmed.ncbi.nlm.nih.gov/35331228/ | Oral erythema multiforme after Pfizer-BioNTech COVID-19 vaccination: a report of four cases | Pertruzzi et al |
| https://pubmed.ncbi.nlm.nih.gov/33914966/ | BNT162b2 mRNA COVID-19 vaccine-induced chilblain-like lesions reinforces the hypothesis of their relationship with SARS-CoV-2 | Piccolo et al (1) |
| https://pubmed.ncbi.nlm.nih.gov/34547122/ | COVID vaccine-induced lichen planus on areas previously affected by vitiligo | Piccolo et al (2) |
| https://pubmed.ncbi.nlm.nih.gov/34750923/ | «Covid arm»: Abnormal side effect after Moderna COVID-19 vaccine | Picone et al (1) |
| https://pubmed.ncbi.nlm.nih.gov/35167108/ | A Case of New-Onset Lichen Planus after COVID-19 Vaccination | Picone et al (2) |
| https://pubmed.ncbi.nlm.nih.gov/33904168/ | Chilblain lesions after COVID-19 mRNA vaccine | Pileri et al |
| https://pubmed.ncbi.nlm.nih.gov/34983709/ | Delayed systemic urticarial reactions following mRNA COVID-19 vaccination | Pitlick et al |
| https://pubmed.ncbi.nlm.nih.gov/34570195/ | Post-vaccination COVID Toes (Chilblains) Exacerbated by Rituximab Infusion Suggests Interferon Activation as Mechanism | Qiao et al |
| https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112292/ | Acral hemorrhages after administration of the second dose of the SARS-CoV-2 vaccine. A post-vaccination reaction? – PMC | Ramos et al |
| https://pubmed.ncbi.nlm.nih.gov/35291527/ | Vesicular Rash Following Immunisation With BTN162b2 Messenger RNA (mRNA) COVID-19 Vaccine: Vaccine Related or Coincidence? | Rashid MRA et al |
| https://pubmed.ncbi.nlm.nih.gov/34928536/ | SCLE manifestation after mRNA COVID-19 vaccination | Rechtien et al |
| https://pubmed.ncbi.nlm.nih.gov/34310777/ | New-onset acral lesions on hands after administration of mRNA-1273 vaccine against SARS-CoV-2: clinical images and histopathological study of three cases | Revilla-Nebreda et al |
| https://pubmed.ncbi.nlm.nih.gov/35393710/ | COVID-19 and autoimmune phenomena: Vitiligo after Astrazeneca vaccine | Riquelme et al |
| https://pubmed.ncbi.nlm.nih.gov/34617317/ | Abrupt onset of Sweet syndrome, pityriasis rubra pilaris, pityriasis lichenoides et varioliformis acuta and erythema multiforme: unravelling a possible common trigger, the COVID-19 vaccine | Sechi et al |
| https://pubmed.ncbi.nlm.nih.gov/35305031/ | Covid-19 and Covid-19 vaccine can slide along sides: a report of two cases of unilateral periflexural exanthema | Sechi et al |
| https://pubmed.ncbi.nlm.nih.gov/35349766/ | Rare cutaneous reactions after ChAdOx1 (Oxford-AstraZeneca) vaccine: 12 case series from Brazil | Seque et al |
| https://pubmed.ncbi.nlm.nih.gov/34751995/ | Lymphomatoid drug reaction developed after BNT162b2 (Comirnaty) COVID-19 vaccine manifesting as pityriasis lichenoides et varioliformis acuta-like eruption | Sernicola et al |
| https://pubmed.ncbi.nlm.nih.gov/34606669/ | Development of oral lichen planus after COVID-19 vaccination – a rare case report | Sharda et al |
| https://pubmed.ncbi.nlm.nih.gov/34109263/ | Localized and generalized urticarial allergic dermatitis secondary to SARS-CoV-2 vaccination in a series of 6 patients | Sidlow et al |
| https://pubmed.ncbi.nlm.nih.gov/34169588/ | Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2 | Solimani et al |
| https://pubmed.ncbi.nlm.nih.gov/34396420/ | Type I Interferon Signature in Chilblains Following SARS-CoV-2 mRNA Vaccine: A Case Report | Souaid et al |
| https://pubmed.ncbi.nlm.nih.gov/35224171/ | Sclerotic skin disease development following COVID-19 vaccination | Sprow et al |
| https://pubmed.ncbi.nlm.nih.gov/34351606/ | Delayed Cutaneous Hypersensitivity Reaction to Vaxzevria (ChAdOx1-S) Vaccine against SARS-CoV-2 | Sprute et al |
| https://pubmed.ncbi.nlm.nih.gov/35191544/ | Exacerbation of systemic lupus erythematosus after receiving mRNA-1273-based coronavirus disease 2019 vaccine | Sugimoto et al |
| https://pubmed.ncbi.nlm.nih.gov/34897823/ | Koebner phenomenon with lichen planus in an area of previous vitiligo after COVID-19 vaccination and the creation of a locus minoris resistentiae | Tatu et al |
| https://pubmed.ncbi.nlm.nih.gov/33900629/ | Acral chilblain-like lesions following inactivated SARS-CoV-2 vaccination | Temmiz et al |
| https://pubmed.ncbi.nlm.nih.gov/34459036/ | Clinicopathological features of cutaneous reactions after mRNA-based COVID-19 vaccines | Tihy et al |
| https://pubmed.ncbi.nlm.nih.gov/34275656/ | Subepidermal blistering eruptions, including bullous pemphigoid, following COVID-19 vaccination | Tomayko et al |
| https://pubmed.ncbi.nlm.nih.gov/34543493/ | Oral lichen planus following the administration of vector-based COVID-19 vaccine (Ad26.COV2.S) | Troeltzsch et al |
| https://pubmed.ncbi.nlm.nih.gov/35152540/ | Newly-developed vitiligo following COVID-19 mRNA vaccine | Uğurer et al |
| https://pubmed.ncbi.nlm.nih.gov/34726187/ | Cutaneous Lymphocytic Vasculitis After Administration of the Second Dose of AZD1222 (Oxford-AstraZeneca) Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination: Casuality or Causality? | Ungari & Pezzarossa |
| https://pubmed.ncbi.nlm.nih.gov/34547113/ | Early atypical injection‐site reactions to COVID‐19 vaccine: a case series | Vaccaro et al |
| https://pubmed.ncbi.nlm.nih.gov/35167784/ | Pityriasis Rosea Associated With COVID-19 Vaccination: A Common Rash Following Administration of a Novel Vaccine | Valk & Bender |
| https://pubmed.ncbi.nlm.nih.gov/34588156/ | Viral-like Reaction or Hypersensitivity? Erythema Multiforme Minor Reaction and Moderate Eosinophilia After the Pfizer-BioNTech BNT162b2 (mRNA-Based) SARS-CoV-2 Vaccine | Vecillas et al |
| https://pubmed.ncbi.nlm.nih.gov/34100306/ | Late-onset cutaneous reaction to BNT162b2 mRNA COVID-19 vaccine in an immunocompromised patient | Weinstock-Guttman & Jakimovski |
| https://pubmed.ncbi.nlm.nih.gov/34676438/ | [Erythema multiforme following COVID-19 vaccination (BNT162b2)] | Wunderlich & Dirschka |
| https://pubmed.ncbi.nlm.nih.gov/34862669/ | Flare-up of generalized pustular psoriasis combined with systemic capillary leak syndrome after coronavirus disease 2019 mRNA vaccination | Yatsuzuka et al |
| https://pubmed.ncbi.nlm.nih.gov/35170156/ | New onset of pemphigus foliaceus following BNT162b2 vaccine | Yıldırıcı et al |
| https://pubmed.ncbi.nlm.nih.gov/34547137/ | A case of bullous pemphigoid after the SARS-CoV-2 mRNA vaccine | Young J et al |
| https://pubmed.ncbi.nlm.nih.gov/34817862/ | Bullous Sweet syndrome following SARS-CoV-2 Oxford AstraZeneca vaccine | Žagar et al |
| https://pubmed.ncbi.nlm.nih.gov/35147269/ | New-onset lichen planus arising after COVID-19 vaccination | Zagaria et al |
| https://pubmed.ncbi.nlm.nih.gov/35174595/ | Lichen Ruber Planus occurring after SARS-CoV-2 vaccination | Zengarini et al (1) |
| https://pubmed.ncbi.nlm.nih.gov/34807495/ | Subacute cutaneous lupus erythematosus induction after SARS-CoV-2 vaccine in a patient with primary biliary cholangitis | Zengarini et al (2) |
| https://pubmed.ncbi.nlm.nih.gov/34726769/ | Bilateral giant cell arteritis with skin necrosis following SARS-CoV-2 vaccination | Gamblichler et al (2) |
| https://pubmed.ncbi.nlm.nih.gov/33991162/ | 20 Post-COVID-19 vaccine-related shingles cases seen at the Las Vegas Dermatology clinic and sent to us via social media | Lee C et al |
| https://pubmed.ncbi.nlm.nih.gov/34327795/ | Cutaneous lymphocytic vasculitis after administration of COVID-19 mRNA vaccine | Vassallo et al |
| https://pubmed.ncbi.nlm.nih.gov/35306713/ | SARS-CoV-2 vaccination-induced cutaneous vasculitis: Report of two new cases and literature review | Abdelmaksoud et al |
| https://pubmed.ncbi.nlm.nih.gov/35141951/ | Reproducible leukocytoclastic vasculitis following severe acute respiratory syndrome coronavirus 2 vaccination | Gambichler et al (3) |
| https://pubmed.ncbi.nlm.nih.gov/34853744/ | Cutaneous Leukocytoclastic Vasculitis Induction Following ChAdOx1 nCoV-19 Vaccine | Shahrigharahkoshan et al |
| https://pubmed.ncbi.nlm.nih.gov/34599716/ | Emergence of de novo cutaneous vasculitis post coronavirus disease (COVID-19) vaccination | Liang et al |
| https://pubmed.ncbi.nlm.nih.gov/34236717/ | Widespread purpura annularis telangiectodes following mRNA SARS-CoV-2 vaccine | Falkenhain-López et al |
| https://pubmed.ncbi.nlm.nih.gov/34247902/ | Henoch-Schönlein purpura presenting post COVID-19 vaccination | Hines et al |
| https://pubmed.ncbi.nlm.nih.gov/35361289/ | Dermatomyositis post vaccine against SARS-COV2 | Coronel et al |
| https://pubmed.ncbi.nlm.nih.gov/34482558/ | Generalized bullous fixed drug eruption after Oxford-AstraZeneca (ChAdOx1 nCoV-19) vaccination | Wantavornprasert et al |
| https://pubmed.ncbi.nlm.nih.gov/34399001/ | Symmetrical drug-related intertriginous and flexural exanthema like eruption associated with COVID-19 vaccination | Lim & Wylie |
| https://pubmed.ncbi.nlm.nih.gov/34398977/ | De novo generalized pustular psoriasis following Oxford-AstraZeneca COVID-19 vaccine | Elamin et al |
| https://pubmed.ncbi.nlm.nih.gov/35306720/ | Generalized erythrodermic psoriasis triggered by vaccination against severe acute respiratory syndrome Coronavirus 2 | Tran TB et al |
| https://pubmed.ncbi.nlm.nih.gov/35299937/ | A severe case of Trichophyton rubrum-caused dermatomycosis exacerbated after COVID-19 vaccination that had to be differentiated from pustular psoriasis | Norimatsu & Norimatsu |
| https://pubmed.ncbi.nlm.nih.gov/35285114/ | A case of new-onset acute generalized pustular psoriasis following Pfizer-BioNTech COVID-19 vaccine | Frioui et al |
| https://pubmed.ncbi.nlm.nih.gov/35315189/ | Pustular rash triggered by Pfizer-BioNTech COVID-19 vaccination: A case report | Rouai et al |
| https://pubmed.ncbi.nlm.nih.gov/34522741/ | Acute generalized pustular psoriasis exacerbated by the COVID-19 vaccine | Perna et al |
| https://pubmed.ncbi.nlm.nih.gov/35066960/ | Exacerbations of generalized pustular psoriasis, palmoplantar psoriasis, and psoriasis vulgaris after mRNA COVID-19 vaccine: A report of three cases | Durmaz et al |
| https://pubmed.ncbi.nlm.nih.gov/35344627/ | Symmetrical drug-related intertriginous and flexural exanthema-like eruption after COVID-19 vaccine | lahouel et al |
| https://pubmed.ncbi.nlm.nih.gov/35106762/ | Cutaneous polyarteritis nodosa following ChAdOx1 nCoV-19 vaccination | Su HA et al (1) |
| https://pubmed.ncbi.nlm.nih.gov/34696186/ | Henoch-Schönlein Purpura Following the First Dose of COVID-19 Viral Vector Vaccine: A Case Report | Sirufo et al |
| https://pubmed.ncbi.nlm.nih.gov/34129749/ | Localized cutaneous reaction to an mRNA COVID-19 vaccine | Edriss et al |
| https://pubmed.ncbi.nlm.nih.gov/34250736/ | Erythema migrans-like rash after Moderna vaccine: An uncommon type of «COVID arm» | Zengarini et al (3) |
| https://pubmed.ncbi.nlm.nih.gov/34813953/ | Delayed hypersensitivity to the Comirnaty coronavirus disease 2019 vaccine presenting with pneumonitis and rash | Stoyanov et al |
| https://pubmed.ncbi.nlm.nih.gov/33657292/ | Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2 | Blumenthal et al |
| https://pubmed.ncbi.nlm.nih.gov/33882228/ | Delayed Large Local Reactions to mRNA Vaccines | Baeck et al |
| https://pubmed.ncbi.nlm.nih.gov/34459023/ | Five Japanese cases of delayed large local reactions to coronavirus disease 2019 vaccines | Sato |
| https://pubmed.ncbi.nlm.nih.gov/34603964/ | Delayed large pruritic eruption to the BNT162b2 mRNA vaccine | Terashima |
| https://pubmed.ncbi.nlm.nih.gov/34310755/ | A skin reaction with rust-like discolouration to mRNA COVID-19 vaccine | Pasternack & Pohjavaara |
| https://pubmed.ncbi.nlm.nih.gov/34657348/ | Response to ‘A skin reaction with rust-like discolouration to mRNA COVID-19 vaccine’ | Kouki et al |
| https://pubmed.ncbi.nlm.nih.gov/34166540/ | Delayed cutaneous reaction to ChAdOx1 nCoV-19 vaccine: Is it an ‘AstraZeneca arm’? | Kim JE et al |
| https://pubmed.ncbi.nlm.nih.gov/34698094/ | Single-Center Clinico-Pathological Case Study of 19 Patients with Cutaneous Adverse Reactions Following COVID-19 Vaccines | Niebel et al (2) |
| https://pubmed.ncbi.nlm.nih.gov/35308066/ | Erythema nodosum after COVID-19 vaccination in a pediatric patient | Hafer et al |
| https://pubmed.ncbi.nlm.nih.gov/34662466/ | Erythema nodosum following the first dose of ChAdOx1-S nCoV-19 vaccine | Cameli et al (2) |
| https://pubmed.ncbi.nlm.nih.gov/34934549/ | First Case of Erythema Nodosum Associated With Pfizer Vaccine | Aly et al |
| https://pubmed.ncbi.nlm.nih.gov/34977819/ | Recurrent erythema nodosum after the second dose of the Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine | Wu X et al |
| https://pubmed.ncbi.nlm.nih.gov/34416052/ | Flagellate purpura associated with COVID-19 vaccination | Heck et al |
| https://pubmed.ncbi.nlm.nih.gov/35296923/ | [Pityriasis rubra pilaris after COVID-19 vaccination: causal relationship or coincidence?] | Bramhoff et al |
| https://pubmed.ncbi.nlm.nih.gov/35284230/ | Fasciitis of the lower leg after COVID-19 vaccination | Ide et al |
| https://pubmed.ncbi.nlm.nih.gov/35194793/ | Unusual contact dermatitis after SARS-CoV-2 vaccinations | Jungwirth et al |
| https://pubmed.ncbi.nlm.nih.gov/34913043/ | Shoulder injury related to COVID-19 vaccine administration: a case report | Wharton et al |
| https://pubmed.ncbi.nlm.nih.gov/34402098/ | Two cases of mild systemic adverse skin eruption after coronavirus disease 2019 vaccination | Nanamori et al |
| https://pubmed.ncbi.nlm.nih.gov/34363258/ | Three cases of vesiculobullous non-IgE-mediated cutaneous reactions to tozinameran (Pfizer-BioNTech COVID-19 vaccine) | Juay & Chandran |
| https://pubmed.ncbi.nlm.nih.gov/34337117/ | Skin necrosis at both COVID-19 vaccine injection sites | Gruenstein & Levitt |
| https://pubmed.ncbi.nlm.nih.gov/34839563/ | Genital necrosis with cutaneous thrombosis after COVID-19 mRNA vaccination | Kuzumi et al |
| https://pubmed.ncbi.nlm.nih.gov/34358176/ | Purpuric Skin Rash in a Patient Undergoing Pfizer-BioNTech COVID-19 Vaccination: Histological Evaluation and Perspectives | Cazzato et al (2) |
| https://pubmed.ncbi.nlm.nih.gov/34293500/ | Delayed cutaneous reactions after the administration of mRNA vaccines against COVID-19 | Guerrero et al |
| https://pubmed.ncbi.nlm.nih.gov/33864927/ | «COVID Arm»: Very delayed large injection site reactions to mRNA COVID-19 vaccines | Ramos & Kelso |
| https://pubmed.ncbi.nlm.nih.gov/34102322/ | Delayed large local reaction to the adenovirus-vectored (ChAdOx1) vaccine | Grobusch et al |
| https://pubmed.ncbi.nlm.nih.gov/34276178/ | Delayed Skin Rash After Receiving SARS-CoV-2 mRNA Moderna Vaccine | Papamanoli et al |
| https://pubmed.ncbi.nlm.nih.gov/34236729/ | Generalized eczematous reactions to the Pfizer-BioNTech COVID-19 vaccine | Leasure et al |
| https://pubmed.ncbi.nlm.nih.gov/34236711/ | Vesiculobullous skin reactions induced by COVID-19 mRNA vaccine: report of four cases and review of the literature | Coto-Segura et al |
| https://pubmed.ncbi.nlm.nih.gov/34129694/ | Delayed local reactions after the first administration of the ChAdOx1 nCoV-19 vaccine | Shin E et al |
| https://pubmed.ncbi.nlm.nih.gov/34086881/ | Incidence and Characteristics of Delayed Injection Site Reaction to the mRNA-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine (Moderna) in a Cohort of Hospital Employees | Jacobson et al |
| https://pubmed.ncbi.nlm.nih.gov/34031953/ | Local reactions to the second dose of the BNT162 COVID-19 vaccine | Tammaro et al |
| https://pubmed.ncbi.nlm.nih.gov/33996313/ | BCG Scar Local Skin Inflammation as a Novel Reaction Following mRNA COVID-19 Vaccines in Two International Healthcare Workers | Lopatynsky-Reyes et al |
| https://pubmed.ncbi.nlm.nih.gov/34930152/ | Reactivation of BCG vaccination scars after vaccination with mRNA-Covid-vaccines: two case reports | Mohamed L et al |
| https://pubmed.ncbi.nlm.nih.gov/35305036/ | Transient inflammation in surgical scars following Covid-19 mRNA vaccination | Ferreli et al |
| https://pubmed.ncbi.nlm.nih.gov/34344774/ | Bacillus Calmette-Guérin scar flare after an mRNA SARS-CoV-2 vaccine | Lim D WT et al |
| https://pubmed.ncbi.nlm.nih.gov/35398905/ | Stevens-Johnson syndrome precipitated by Moderna Inc. COVID-19 vaccine: a case-based review of literature comparing vaccine and drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis | Padniewski et al |
| https://pubmed.ncbi.nlm.nih.gov/35274363/ | Another case of generalized bullous fixed drug eruption following an adenoviral vector-based COVID-19 vaccine (ChAdOx1 nCov-19) | Salem et al |
| https://pubmed.ncbi.nlm.nih.gov/34582621/ | Oral pemphigus after COVID-19 vaccination | Thongprasom et al |
| https://pubmed.ncbi.nlm.nih.gov/34718079/ | Vulvar Aphthous Ulcer Following Pfizer-BioNTech COVID-19 Vaccine – A Case Report | Drucker et al |
| https://pubmed.ncbi.nlm.nih.gov/34706274/ | Vulvar Aphthous Ulcer in an Adolescent After Pfizer-BioNTech (BNT162b2) COVID-19 Vaccination | Wojcicki & O’Brien |
| https://pubmed.ncbi.nlm.nih.gov/34888935/ | Vulvar aphthous ulcer after COVID-19 vaccination | Popatia & Chiu |
| https://pubmed.ncbi.nlm.nih.gov/35413297/ | Acute Genital Ulceration After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination and Infection | Hsu T et al |
| https://pubmed.ncbi.nlm.nih.gov/35114426/ | Ulcers on the bilateral palate mucosa following mRNA-based vaccination for coronavirus disease 2019 (COVID-19): A case report | Maeda et al |
| https://pubmed.ncbi.nlm.nih.gov/35260129/ | Various painful oral adverse reactions following COVID-19 vaccination: a case series | Chun Y et al |
| https://pubmed.ncbi.nlm.nih.gov/34753210/ | Eosinophilic dermatosis after AstraZeneca COVID-19 vaccination | Cinotti et al |
| https://pubmed.ncbi.nlm.nih.gov/34487570/ | Psoriasis exacerbation after first dose of AstraZeneca coronavirus disease 2019 vaccine | Fang et al |
| https://pubmed.ncbi.nlm.nih.gov/34231301/ | Exacerbation of psoriasis following COVID-19 vaccination in a patient previously treated with PD-1 inhibitor | Mieczkowska et al |
| https://pubmed.ncbi.nlm.nih.gov/34363647/ | Psoriasis exacerbation after COVID-19 vaccination: a report of 14 cases from a single centre | Sotiriou et al |
| https://pubmed.ncbi.nlm.nih.gov/35015916/ | COVID vaccine-induced pustular psoriasis in patients with previous plaque type psoriasis | Piccolo et al |
| https://pubmed.ncbi.nlm.nih.gov/34309932/ | New onset of mainly guttate psoriasis after COVID-19 vaccination: a case report | Lehmann et al |
| https://pubmed.ncbi.nlm.nih.gov/34236728/ | New onset of remitting seronegative symmetrical synovitis with pitting oedema and palmoplantar psoriasis flare-up after Sars-Cov-2 vaccination | Quattrini et al |
| https://pubmed.ncbi.nlm.nih.gov/34348912/ | Remitting seronegative symmetrical synovitis with pitting oedema following BNT162b2 mRNA COVID-19 vaccination | Parperis & Constantinou |
| https://pubmed.ncbi.nlm.nih.gov/35236680/ | Marked increase of interferon-β after BNT162b2 mRNA vaccination: a case of polyarthritis with pleurisy | Shimagami et al |
| https://pubmed.ncbi.nlm.nih.gov/35079580/ | Psoriatic flare following Oxford-AstraZeneca ChAdOx1 COVID-19 and influenza vaccines | The & Leow |
| https://pubmed.ncbi.nlm.nih.gov/34350668/ | Onset/flare of psoriasis following the ChAdOx1 nCoV-19 Corona virus vaccine (Oxford-AstraZeneca/Covishield): Report of two cases | Nagrani et al |
| https://pubmed.ncbi.nlm.nih.gov/34713443/ | De novo guttate psoriasis following coronavirus disease 2019 vaccination | Song WJ et al |
| https://pubmed.ncbi.nlm.nih.gov/35176180/ | A case of psoriatic spondyloarthritis exacerbation triggered by COVID-19 messenger RNA vaccine | Ohmura et al |
| https://pubmed.ncbi.nlm.nih.gov/35004790/ | Exacerbation of Psoriasis Following COVID-19 Vaccination: Report From a Single Center | Huang & Tsai |
| https://pubmed.ncbi.nlm.nih.gov/35170153/ | Erythrodermic psoriasis eruption associated with SARS-CoV-2 vaccination | Nia et al |
| https://pubmed.ncbi.nlm.nih.gov/34363731/ | Pityriasis rosea following SARS-CoV-2 vaccination: A case series | Temiz et al |
| https://pubmed.ncbi.nlm.nih.gov/34237178/ | Pityriasis rosea developing after COVID-19 vaccination | Marcantonio-Santa Cruz et al |
| https://pubmed.ncbi.nlm.nih.gov/34110010/ | Pityriasis rosea after mRNA COVID-19 vaccination | Abdullah et al |
| https://pubmed.ncbi.nlm.nih.gov/34740803/ | Pityriasis Rosea Shortly After mRNA-1273 COVID-19 Vaccination | Shin SH et al |
| https://pubmed.ncbi.nlm.nih.gov/34165237/ | Post Covid-19 vaccination papulovesicular pityriasis rosea-like eruption in a young male | Adya et al |
| https://pubmed.ncbi.nlm.nih.gov/33904157/ | Pityriasis rosea-like eruption after Pfizer-BioNTech COVID-19 vaccination | Carballido Vázquez & Morgado |
| https://pubmed.ncbi.nlm.nih.gov/34435935/ | Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccine | Cohen et al |
| https://pubmed.ncbi.nlm.nih.gov/35156062/ | Pityriasis rosea-like rash after messenger RNA COVID-19 vaccination: A case report and review of the literature | Buckley et al |
| https://pubmed.ncbi.nlm.nih.gov/35012825/ | Pityriasis Rosea-like eruptions following COVID-19 mRNA-1273 vaccination: A case report and literature review | Wang CS et al |
| https://pubmed.ncbi.nlm.nih.gov/34585750/ | Atypical pityriasis rosea associated with mRNA COVID-19 vaccine | Bostan & Jarbou |
| https://pubmed.ncbi.nlm.nih.gov/35518792/ | Inverse pityriasis rosea secondary to COVID-19 vaccination | Fenner et al |
| https://pubmed.ncbi.nlm.nih.gov/34762355/ | Benign cutaneous reactions post-COVID-19 vaccination: A case series of 16 patients from a tertiary care center in India | Agarwal et al |
| https://pubmed.ncbi.nlm.nih.gov/34436620/ | Exacerbation of Hailey-Hailey Disease Following SARS-CoV-2 Vaccination | Armoni-Weiss et al |
| https://pubmed.ncbi.nlm.nih.gov/35211316/ | De novo IgA vasculitis following adenovirus-based SARS-CoV-2 vaccination | Oniszczuk et al |
| https://pubmed.ncbi.nlm.nih.gov/33998677/ | Recurrent varicella following SARS-CoV-2 vaccination with BNT162b2 | Nanova et al |
| https://pubmed.ncbi.nlm.nih.gov/35429051/ | Disseminated herpes zoster in an immune-competent patient after SARS-CoV-2 vaccine (BNT162b2 Comirnaty, Pfizer) | Zengarini et al (4) |
| https://pubmed.ncbi.nlm.nih.gov/34121663/ | Hypersensitivity to Covid-19 Vaccine Confirmed by a Positive Skin Test Result: A Case Report | Pérez-Codesido et al |
| https://pubmed.ncbi.nlm.nih.gov/34132638/ | Immediate-Type Hypersensitivity to Polyethylene Glycol (PEG) and a PEG-Containing COVID-19 Vaccine Revealed by Intradermal Testing | Pickert et al |
| https://pubmed.ncbi.nlm.nih.gov/35664444/ | Vaccine Toes Are the New COVID Toes | Hodge et al |
| https://pubmed.ncbi.nlm.nih.gov/35256820/ | Acute exacerbation of psoriasis after COVID-19 Pfizer vaccination | Lopez ED et al |
| https://pubmed.ncbi.nlm.nih.gov/35373779/ | Severe injection site reaction ensuing the first dose of mRNA COVID-19 vaccine: a case report | Pierobon et al |
| https://pubmed.ncbi.nlm.nih.gov/35252516/ | COVID-19 vaccine-associated dermatomyositis | Wu M et al |
| https://pubmed.ncbi.nlm.nih.gov/35049235/ | Transient lower extremity lymphedema following COVID-19 vaccination: A case report | Chung JH et al |
| https://pubmed.ncbi.nlm.nih.gov/34920834/ | The histologic and molecular correlates of COVID-19 vaccine-induced changes in the skin | Magro et al |
| https://pubmed.ncbi.nlm.nih.gov/35355380/ | Dermatomyositis following COVID-19 vaccination | Venkateswaran et al |
| https://pubmed.ncbi.nlm.nih.gov/35223429/ | Post-COVID-19 vaccination shoulder abscess and pleuroparenchymal pulmonary lesion due to Burkholderia pseudomallei | Mohanty et al |
| https://pubmed.ncbi.nlm.nih.gov/34310763/ | Small-vessel vasculitis following Oxford-AstraZeneca vaccination against SARS-CoV-2 | Guzmán-Pérez et al |
| https://pubmed.ncbi.nlm.nih.gov/34363713/ | Cutaneous reactions to inactivated SARS-CoV-2 vaccine and ChAdOx1-S (recombinant) vaccine against SARS-CoV-2: a case series from the Philippines | Yu JN et al |
| https://pubmed.ncbi.nlm.nih.gov/34703816/ | Acute urticarial rash after COVID-19 vaccination containing Polysorbate 80 | Burlando et al |
| https://pubmed.ncbi.nlm.nih.gov/35470099/ | Fixed drug eruption after Pfizer-BioNTech COVID-19 vaccine: A case report | Lellig et al |
| https://pubmed.ncbi.nlm.nih.gov/34384729/ | Stevens-Johnson syndrome post second dose of Pfizer COVID-19 vaccine: a case report | Elboraey & Essa |
| https://pubmed.ncbi.nlm.nih.gov/35133674/ | Stevens-Johnson syndrome induced by Vaxvetria (AZD1222) COVID-19 vaccine | Aimo et al |
| https://pubmed.ncbi.nlm.nih.gov/34540442/ | Toxic Epidermal Necrolysis Post COVID-19 Vaccination – First Reported Case | Bakir et al |
| https://pubmed.ncbi.nlm.nih.gov/34416058/ | A Bullous Eruption following the Pfizer-BioNTech COVID-19 vaccination | D’Cruz et al |
| https://pubmed.ncbi.nlm.nih.gov/34524252/ | Transient Eyelid Edema Following COVID-19 Vaccination | Austria et al |
| https://pubmed.ncbi.nlm.nih.gov/34692313/ | Chronic Spontaneous Urticaria After COVID-19 Vaccine | Thomas J et al |
| https://pubmed.ncbi.nlm.nih.gov/35284208/ | Chronic spontaneous urticaria following ChAdOx1-S COVID-19 vaccination | Suan & Lee |
| https://pubmed.ncbi.nlm.nih.gov/34857596/ | COVID-19 vaccine-induced cellulitis and myositis | Ramalingam et al |
| https://pubmed.ncbi.nlm.nih.gov/34934701/ | Delayed-type hypersensitivity skin reaction to Covid-19 vaccine | Robb & Robb |
| https://pubmed.ncbi.nlm.nih.gov/34611073/ | COVID Arm After Moderna Booster in Healthcare Worker: A Case Report | Saifuddin et al |
| https://pubmed.ncbi.nlm.nih.gov/34153381/ | Radiation Recall Phenomenon Following COVID-19 Vaccination | Stewart & McDowell |
| https://pubmed.ncbi.nlm.nih.gov/35103229/ | Breast Radiation Recall Phenomenon After Astra-Zeneca COVID-19 Vaccine: A Case Series | Marples et al |
| https://pubmed.ncbi.nlm.nih.gov/33677050/ | COVID-19 Vaccine-Induced Radiation Recall Phenomenon | Soyfer et al |
| https://pubmed.ncbi.nlm.nih.gov/35101198/ | In Regard to Soyfer et al | Ebner et al |
| https://pubmed.ncbi.nlm.nih.gov/35036285/ | Radiation recall phenomenon after administration of the mRNA-1273 SARS-CoV-2 vaccine | Ishikawa et al |
| https://pubmed.ncbi.nlm.nih.gov/34739397/ | Radiation Recall Pneumonitis on FDG PET/CT Triggered by COVID-19 Vaccination | Hughes NM et al |
| https://pubmed.ncbi.nlm.nih.gov/34416044/ | Two cases of papulo-pustular rosacea-like eruptions following COVID-19 vaccinations | Ciccarese et al (2) |
| https://pubmed.ncbi.nlm.nih.gov/34951399/ | Multiform Erythema After COVID-19 mRNA Vaccination | Majenka et al |
| https://pubmed.ncbi.nlm.nih.gov/35615160/ | Case series ( Journal of The American Academy of Dermatology Cases Reports) Chronic spontaneous urticaria following COVID-19 vaccination | de Montjoye et al |
| https://pubmed.ncbi.nlm.nih.gov/34427024/ | Exacerbation of plaque psoriasis after inactivated and BNT162b2 mRNA COVID-19 vaccines: A report of two cases | Bostan E et ak |
| https://pubmed.ncbi.nlm.nih.gov/34937807/ | Delayed-type hypersensitivity reactions to Pfizer BioNTech SARS-CoV-2 vaccine | Beyaz et al |
| https://pubmed.ncbi.nlm.nih.gov/35097177/ | Erythema multiforme reactions after Pfizer/BioNTech (BNT162b2) and Moderna (mRNA-1273) COVID-19 vaccination: A case series | Karatas et al |
| https://pubmed.ncbi.nlm.nih.gov/34693548/ | Annular plaques mimicking Rowell’s syndrome in the course of coronavirus disease 2019 mRNA vaccines: An overlooked phenomenon? | Niebel et al (3) |
| https://pubmed.ncbi.nlm.nih.gov/34611542/ | Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine | Ricardo & Lipner |
| https://pubmed.ncbi.nlm.nih.gov/34978352/ | Sarcoidal immune reaction following SARS-CoV-2 vaccination | Rached et al |
| https://pubmed.ncbi.nlm.nih.gov/35499440/ | An acute, ulcerative, sarcoidal tattoo reaction following SARS-CoV-2 mRNA-1273 vaccination | Manci et al |
| https://pubmed.ncbi.nlm.nih.gov/34895746/ | Cutaneous vasculitis due to COVID-19 vaccination | Gázquez Aguilera et al |
| https://pubmed.ncbi.nlm.nih.gov/34759023/ | Nicolau Syndrome After Glatiramer Acetate Injection in Close Proximity to Administration of SARS-CoV-2 mRNA Vaccine | Sy etal |
| https://pubmed.ncbi.nlm.nih.gov/35073431/ | Incident bullous pemphigoid in a psoriatic patient following mRNA-1273 SARS-CoV-2 vaccination | Hung & Chi |
| https://pubmed.ncbi.nlm.nih.gov/34880971/ | Drug-induced lichenoid exanthema by a vaccine against COVID-19 (Vaxzevria) | Ziraldo et al |
| https://pubmed.ncbi.nlm.nih.gov/35522122/ | Eosinophilic cellulitis in response to BNT162b2 COVID-19 vaccination | Ikediobi et al |
| https://pubmed.ncbi.nlm.nih.gov/35022253/ | Post BNT162b2 mRNA COVID-19 vaccination Henoch-Schӧnlein Pupura | Wang SSY |
| https://pubmed.ncbi.nlm.nih.gov/35431308/ | Erythema Multiforme after BNT162b2 Vaccination | Katayama & Ota |
| https://pubmed.ncbi.nlm.nih.gov/35079635/ | Perniosis-like lesions after vaccination with mRNA against COVID-19 | Pérez-López et al (2) |
| https://pubmed.ncbi.nlm.nih.gov/35131890/ | Development of anti-NXP2 dermatomyositis following Comirnaty COVID-19 vaccination | Lee AYS et al |
| https://pubmed.ncbi.nlm.nih.gov/35075691/ | Psoriasis flare-up after AZD1222 and BNT162b2 COVID-19 mRNA vaccines: report of twelve cases from a single centre | Koumaki et al (1) |
| https://pubmed.ncbi.nlm.nih.gov/35661906/ | Anti-MDA5 dermatomyositis after COVID-19 vaccination: a case-based review | Gonzalez D et al |
| https://pubmed.ncbi.nlm.nih.gov/34776189/ | Effect of gentle exercises on injection site reaction after Covid-19 vaccination. A case report | Kalia |
| https://pubmed.ncbi.nlm.nih.gov/35584258/ | Lymphomatoid papulosis (LyP) after AZD1222 and BNT162b2 COVID-19 vaccines | Koumaki et al (2) |
| https://pubmed.ncbi.nlm.nih.gov/33974494/ | Recurrence of primary cutaneous CD30-positive lymphoproliferative disorder following COVID-19 vaccination | Brumfiel et al |
| https://pubmed.ncbi.nlm.nih.gov/34228815/ | Primary cutaneous anaplastic large-cell lymphoma with marked spontaneous regression of organ manifestation after SARS-CoV-2 vaccination | Gambicher et al (4) |
| https://pubmed.ncbi.nlm.nih.gov/34478204/ | Cutaneous adverse effects and contraindications to COVID-19 vaccination; four cases and an illustrative review from an Asian country | Choi E et al |
| https://pubmed.ncbi.nlm.nih.gov/35607272/ | Cutaneous adverse reactions following the Pfizer/BioNTech COVID-19 vaccine | Luo & Oakley |
| https://pubmed.ncbi.nlm.nih.gov/35583958/ | New onset of psoriasis following COVID-19 vaccination | Tran TNA et al |
| https://pubmed.ncbi.nlm.nih.gov/35073411/ | A case of morphea following the COVID-19 mRNA vaccine: on the basis of viral spike proteins | Metin & Celepeli |
| https://pubmed.ncbi.nlm.nih.gov/35751559/ | Cutaneous leukocytoclastic vasculitis following COVID-19 vaccination with Ad26.COV2.S vaccine: a case report and literature review | Betetto et al |
| https://pubmed.ncbi.nlm.nih.gov/35698236/ | Chilblain-like lesions onset during SARS-CoV-2 infection in a COVID-19-vaccinated adolescent: case report and review of literature | Paparella et al |
| https://pubmed.ncbi.nlm.nih.gov/35613221/ | Facial Angioedema after the first dose of Covishield (adenovirus-vectored severe acute respiratory syndrome coronavirus 2 vaccine): follow-up after the second and third booster doses | Eyer-Silva & Leme |
| https://pubmed.ncbi.nlm.nih.gov/35606031/ | Erythema multiforme in a young adult following COVID-19 infection and vaccination in Tanzania | Manji et al |
| https://pubmed.ncbi.nlm.nih.gov/35373396/ | Histopathological analysis of skin reactions after coronavirus disease 2019 vaccination: Increment in number of infiltrated plasmacytoid dendritic cell | Watanabe H et al |
| https://pubmed.ncbi.nlm.nih.gov/35348281/ | Development of severe pemphigus vulgaris following ChAdOx1 nCoV-19 vaccination and review of literature | Singh et al |
| https://pubmed.ncbi.nlm.nih.gov/35278243/ | Case of lichen planus pigmentosus-inversus after Oxford-AstraZeneca COVID-19 vaccine: cause or coincidence? | Sun L et al |
| https://pubmed.ncbi.nlm.nih.gov/35258436/ | Localized lipoatrophy and inadvertent subcutaneous administration of a COVID-19 vaccine | Cook IF |
| https://pubmed.ncbi.nlm.nih.gov/34811862/ | COVID vaccination in patients under treatment with rituximab: A presentation of two cases from Iran and a review of the current knowledge with a specific focus on pemphigus | Hatami et al |
| https://pubmed.ncbi.nlm.nih.gov/35080255/ | Can Covid-19 vaccines cause or exacerbate bullous pemphigoid? A report of seven cases from one center | Afacan et al |
| https://pubmed.ncbi.nlm.nih.gov/34928518/ | Bullous pemphigoid in a young male after COVID-19 mRNA vaccine: a report and brief literature review | Pauluzzi et al |
| https://pubmed.ncbi.nlm.nih.gov/34773638/ | Bullous pemphigoid after SARS-CoV-2 vaccination: spike-protein-directed immunofluorescence confocal microscopy and T-cell-receptor studies | Gamblichler et al (5) |
| https://pubmed.ncbi.nlm.nih.gov/35031201/ | Morbilliform rashes as an unusual manifestation of vaccine-induced immune thrombotic thrombocytopenia | Yang WT et al |
| https://pubmed.ncbi.nlm.nih.gov/34081806/ | COVID-19 vaccine-induced Stevens-Johnson syndrome | Dash S et al |
| https://pubmed.ncbi.nlm.nih.gov/34877762/ | Papular acrodermatitis of childhood-like eruption triggered by SARS-CoV-2 vaccination: Report of two cases | Villagrasa-Boli et al |
| https://pubmed.ncbi.nlm.nih.gov/34874824/ | Catastrophic antiphospholipid syndrome triggered by mRNA COVID-19 vaccine | Moreno-Torres et al |
| https://pubmed.ncbi.nlm.nih.gov/35365342/ | Erythema nodosum triggered by BNT162b2 mRNA COVID-19 vaccine | Juddoo et al |
| https://pubmed.ncbi.nlm.nih.gov/35099065/ | Leukocytoclastic vasculitis in possible relation to the BNT162b2 mRNA COVID-19 vaccine | Carrillo-Garcia et al |
| https://pubmed.ncbi.nlm.nih.gov/34984777/ | Erythema nodosum after Moderna mRNA-1273 COVID-19 vaccine | Teymour et al |
| https://pubmed.ncbi.nlm.nih.gov/35506318/ | Erythema nodosum after COVID-19 vaccine | Maranini et al |
| https://pubmed.ncbi.nlm.nih.gov/34817063/ | An unusual presentation of pemphigus foliaceus following COVID-19 vaccination | Lua ACY et al |
| https://pubmed.ncbi.nlm.nih.gov/34731529/ | Erythema annulare centrifugum induced by COVID-19 vaccination | Kim JC et al |
| https://pubmed.ncbi.nlm.nih.gov/34720009/ | Images in Vascular Medicine: Leukocytoclastic vasculitis after COVID-19 vaccine booster | Dicks & Gray |
| https://pubmed.ncbi.nlm.nih.gov/34699970/ | Delayed angioedema after administration of the severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine | Watts MM et al |
| https://pubmed.ncbi.nlm.nih.gov/34663612/ | {Erythema at the site of a Bacille Calmette–Guérin vaccine scar after obtaining a dose of the SARS-CoV-2 messenger RNA vaccine} Érythème au site d’une cicatrice du vaccin bacille de Calmette–Guérin après l’obtention d’une dose du vaccin à ARN messager contre le SRAS-CoV-2 | Lim DWT et al |
| https://pubmed.ncbi.nlm.nih.gov/35567509/ | Marie Antoinette syndrome following COVID-19 vaccination | Baffa et al (2) |
| https://pubmed.ncbi.nlm.nih.gov/34291744/ | Unique Case of Urticarial Skin Eruptions After COVID-19 Vaccination | Baraldi et al |
| https://pubmed.ncbi.nlm.nih.gov/34260095/ | Severe cutaneous adverse reaction following COVID-19 vaccination and immunotherapy: a second hit? | Hussain et al |
| https://pubmed.ncbi.nlm.nih.gov/34518832/ | Lymphadenopathy with florid lymphoid and Langerhans cell hyperplasia and hemophagocytosis mimicking lymphoma after COVID-19 mRNA vaccination | Tintle & Chen |
| https://pubmed.ncbi.nlm.nih.gov/33972089/ | COVID arm and PET/FDG imaging | Barriere & Bondouy |
| https://pubmed.ncbi.nlm.nih.gov/33835617/ | Ribonucleic acid COVID-19 vaccine-associated cutaneous adverse drug events: a case series of two patients | Lam M et al |
| https://pubmed.ncbi.nlm.nih.gov/34594203/ | Darier’s Disease Flare following COVID-19 Vaccine | Elbæk et al |
| https://pubmed.ncbi.nlm.nih.gov/33823270/ | Covid-19 vaccine and autoimmunity: Awakening the sleeping dragon | Akinosoglou et al |
| https://pubmed.ncbi.nlm.nih.gov/34145775/ | Skin rashes after SARS-CoV-2 vaccine: which relationship, if any? | Patruno et al |
| https://pubmed.ncbi.nlm.nih.gov/35066922/ | Cutaneous arteritis following mRNA-1273 Moderna COVID-19 vaccination | Ogawa et al |
| https://pubmed.ncbi.nlm.nih.gov/35049059/ | Massive bullous local reaction following administration of Ad26.COV2.S COVID-19 vaccine | Montero-Menárguez et al |
| https://pubmed.ncbi.nlm.nih.gov/34841025/ | Widespread cutaneous reaction to the Johnson & Johnson Ad26.COV2.S vaccine | Sowell et al |
| https://pubmed.ncbi.nlm.nih.gov/33997209/ | Widespread annular eruption after Ad26.COV2.S COVID-19 vaccine | Song & Wong |
| https://pubmed.ncbi.nlm.nih.gov/35770484/ | New-onset systemic lupus erythematosus after ChAdOX1 nCoV-19 and alopecia areata after BNT162b2 vaccination against SARS-CoV-2 | Gamonal et al |
| https://pubmed.ncbi.nlm.nih.gov/35789521/ | Intractable alopecia areata following the second dose of COVID-19 vaccination: Report of two cases | Chen CH et al |
| https://pubmed.ncbi.nlm.nih.gov/34559937/’ | Alopecia areata after ChAdOx1 nCoV-19 vaccine (Oxford/AstraZeneca): a potential triggering factor? | Essam et al |
| https://pubmed.ncbi.nlm.nih.gov/35223675/ | Alopecia areata after COVID-19 vaccination | Gallo et al |
| https://pubmed.ncbi.nlm.nih.gov/35107173/ | Alopecia areata following COVID-19 vaccination: vaccine-induced autoimmunity? | Lee MM et al |
| https://pubmed.ncbi.nlm.nih.gov/35571458/ | Letter in Reply: Alopecia areata after SARS-CoV-2 vaccination | Lo et al |
| https://pubmed.ncbi.nlm.nih.gov/34741583/ | Recurrence of alopecia areata after covid-19 vaccination: A report of three cases in Italy – PubMed | Rossi et al |
| https://pubmed.ncbi.nlm.nih.gov/34931171/ | Alopecia areata after SARS-CoV-2 vaccination | Scollan et al |
| https://pubmed.ncbi.nlm.nih.gov/35716105/ | Cutaneous manifestations following COVID-19 vaccination: A report of 25 cases | Shakoei et al |
| https://pubmed.ncbi.nlm.nih.gov/35642187/ | Alopecia universalis with unusual histopathologic features after vaccination with ChAdOx1 nCoV-19 (AZD1222) | Ho JD et al |
| https://pubmed.ncbi.nlm.nih.gov/35379574/ | Alopecia areata following ChAdOx1 nCoV-19 vaccination (Oxford/AstraZeneca) | Su HA et al (2) |
| https://pubmed.ncbi.nlm.nih.gov/35070594/ | Alopecia Areata Treated with Advanced Platelet-rich Fibrin Using Micronization | Vazquez et al |
| https://pubmed.ncbi.nlm.nih.gov/35771095/ | Influence of Covid-19 vaccination on immune-mediated skin diseases | Alelq et al |
| https://pubmed.ncbi.nlm.nih.gov/35754159/ | Cutaneous lupus erythematosus-like reaction arising after COVID-19 vaccination | Rose C et al |
| https://pubmed.ncbi.nlm.nih.gov/35624558/ | Subacute cutaneous lupus erythematosus following ChAdOx1 nCoV-19 vaccination | Wang WY et al |
| https://pubmed.ncbi.nlm.nih.gov/35529074/ | A case of pityriasis rubra pilaris following AstraZeneca COVID-19 vaccine | Wada et al |
| https://pubmed.ncbi.nlm.nih.gov/35465138/ | Pityriasis rubra pilaris potentially triggered by messenger RNA-1273 COVID vaccine | Ajebo et al |
| https://pubmed.ncbi.nlm.nih.gov/35278239/ | Pityriasis rubra pilaris (type I) following ChAdOx1 COVID-19 vaccine: A report of two cases with successful treatment with oral isotretinoin | Criado et al |
| https://pubmed.ncbi.nlm.nih.gov/35968197/ | Leukocytoclastic Vasculitis following the First Dose of the Elasomeran COVID-19 Vaccination | Casale et al |
| https://pubmed.ncbi.nlm.nih.gov/36000937/ | Toxic epidermal necrolysis after first dose of Pfizer-BioNTech (BNT162b2) vaccination with pharmacogenomic testing | Siripipattanamongkol et al |
| https://pubmed.ncbi.nlm.nih.gov/35986626/ | Stevens-Johnson syndrome after ChAdOx1 nCoV-19 vaccine | da Cruz Gouveia et al |
| https://pubmed.ncbi.nlm.nih.gov/35966160/ | Stevens-Johnson syndrome related with Comirnaty® coronavirus disease 2019 vaccine | Marcelino et al |
| https://pubmed.ncbi.nlm.nih.gov/34466640/ | Acute generalized exanthematous pustulosis induced by Moderna COVID-19 messenger RNA vaccine | Agaronov et al |
| https://pubmed.ncbi.nlm.nih.gov/34485656/ | Hypersensitivity reactions following the Moderna messenger RNA-1273 vaccine | Drohan et al |
| https://pubmed.ncbi.nlm.nih.gov/34485657/ | Cutaneous hypersensitivity reaction with acute hepatitis following COVID-19 vaccine | Wong CY & Rios |
| https://pubmed.ncbi.nlm.nih.gov/34495381/ | Vasculitis and bursitis on [ 18 F]FDG-PET/CT following COVID-19 mRNA vaccine: post hoc ergo propter hoc? | Schierz et al |
| https://pubmed.ncbi.nlm.nih.gov/34611627/ | Cutaneous vasculitis following COVID-19 vaccination | Cavalli et al |
| https://pubmed.ncbi.nlm.nih.gov/34746453/ | «COVID arm» detected by MR neurography | Komiya et al |
| https://pubmed.ncbi.nlm.nih.gov/34816549/ | Pityriasis rosea after Moderna mRNA-1273 vaccine: A case series | Martora et al |
| https://pubmed.ncbi.nlm.nih.gov/34821411/ | A case of erythroderma with elevated serum immunoglobulin E and thymus and activation-regulated chemokine levels following coronavirus disease 2019 vaccination | Iwasawa et al (1) |
| https://pubmed.ncbi.nlm.nih.gov/34961975/ | Lichenoid drug eruption after coronavirus disease 2019 vaccination | Baba et al |
| https://pubmed.ncbi.nlm.nih.gov/35092306/ | Bullous neutrophilic dermatosis with severe acral oedema post-COVID-19 mRNA vaccination | Goubar et al |
| https://pubmed.ncbi.nlm.nih.gov/35184341/ | Pityriasis lichenoides et varioliformis acuta after SARS-CoV-2 infection and relapse after vaccination | Mäkilä et al |
| https://pubmed.ncbi.nlm.nih.gov/35653233/ | Sweet-like syndrome and multiple COVID arm syndrome following COVID-19 vaccines: ‘specific’ patterns in a series of 192 patients | Darrigade et al |
| https://pubmed.ncbi.nlm.nih.gov/35698860/ | Six cases of pityriasis rosea following SARS-CoV-2 vaccination with BNT162b2 | Ramot et al |
| https://pubmed.ncbi.nlm.nih.gov/34337124/ | Cutaneous small vessel vasculitis following single-dose Janssen Ad26.COV2.S vaccination | Berry CT et al |
| https://pubmed.ncbi.nlm.nih.gov/34337193/ | Report of Three Cases of Minimal Change Disease Following the Second Dose of mRNA SARS-CoV-2 COVID-19 Vaccine | Salem F et al |
| https://pubmed.ncbi.nlm.nih.gov/34363637/ | Rare cutaneous adverse effects of COVID-19 vaccines: a case series and review of the literature | Annabi et al |
| https://pubmed.ncbi.nlm.nih.gov/34366434/ | [Lipschütz Ulcers After the AstraZeneca COVID-19 Vaccine] | González-Romero et al |
| https://pubmed.ncbi.nlm.nih.gov/34374333/ | Pityriasis Rosea as a Possible Complication of Vaccination Against COVID-19 | Dormann et al |
| https://pubmed.ncbi.nlm.nih.gov/34414254/ | Cutaneous skin manifestation following messenger RNA Moderna SARS-CoV-2 vaccine with dermal hypersensitivity reaction histopathology | Chopra et al |
| https://pubmed.ncbi.nlm.nih.gov/34487574/ | Oxford-AstraZeneca COVID-19 vaccine-induced acute localized exanthematous pustulosis | Wu RW & Lin TK |
| https://onlinelibrary.wiley.com/doi/epdf/10.1002/cia2.12278 | Persistent varicella zoster virus infection following mRNA COVID-19 vaccination was associated with the presence of encoded spike protein in the lesion | Yamamoto M |
| https://pubmed.ncbi.nlm.nih.gov/36072649/ | Coexistence of Pemphigus Vulgaris and Lichen Planus following COVID-19 Vaccination | Aryanian et al (2) |
| https://pubmed.ncbi.nlm.nih.gov/36068793/ | Widespread cutaneous eruption following COVID-19 vaccine in the setting of immunotherapy | El-Behaedi et al |
| https://pubmed.ncbi.nlm.nih.gov/36062201/ | A case of recurrent fixed drug eruption following two different coronavirus disease 2019 vaccination verified through intradermal and patch tests | Seol EJ et al |
| https://pubmed.ncbi.nlm.nih.gov/35604041/ | Nail psoriasis: a rare mRNA COVID-19 vaccine reaction | Lamberti A et al |
| https://pubmed.ncbi.nlm.nih.gov/36098769/ | New-onset systemic lupus erythematosus following BNT162b2 mRNA COVID-19 vaccine: a case series and literature review | Sagy et al |
| https://pubmed.ncbi.nlm.nih.gov/36035769/ | Sever erythema multiforme post-COVID-19 moderna vaccine: Case report and literature review | Fadul et al |
| https://pubmed.ncbi.nlm.nih.gov/36035747/ | COVID-19 Vaccination Related Exacerbations of Hair Loss in Patients with Moderate to Severe Alopecia Areata on Systemic Therapy | Babadjouni et al |
| https://pubmed.ncbi.nlm.nih.gov/36004038/ | Pityriasis Rosea Following Pfizer-BioNTech Vaccination in an Adolescent Girl | Rubaian et al |
| https://pubmed.ncbi.nlm.nih.gov/35991953/ | Sweet syndrome following Moderna COVID-19 vaccine: A case report | Pelchat et al |
| https://pubmed.ncbi.nlm.nih.gov/35975094/ | Alopecia Areata Universalis Precipitated by SARS-CoV-2 Vaccine: A Case Report and Narrative Review | Abdalla & Ebrahim |
| https://pubmed.ncbi.nlm.nih.gov/35966159/ | Delayed urticaria after BNT162b2 booster vaccination at previous intradermal test site with severe acute respiratory syndrome-coronavirus-2 spike protein | Triwatcharikorn et al |
| https://pubmed.ncbi.nlm.nih.gov/35936173/ | COVID-19 Vaccine Booster-Induced Dermatographism | Amjad et al |
| https://pubmed.ncbi.nlm.nih.gov/35922892/ | Eosinophil-rich linear IgA bullous dermatosis induced by mRNA COVID-19 booster vaccine | Nahm et al |
| https://pubmed.ncbi.nlm.nih.gov/35916826/ | Eyelid edema following the first Pfizer-BioNTech COVID-19 vaccination: is it a coincidence? | Baysal & Gobeka |
| https://pubmed.ncbi.nlm.nih.gov/35911257/ | Dyshidrosiform Bullous Pemphigoid Triggered by COVID-19 Vaccination | Shansal |
| https://pubmed.ncbi.nlm.nih.gov/35892478/ | Pseudo-Pemphigoid Gestationis Eruption Following SARS-CoV-2 Vaccination with mRNA Vaccine | de Lorenzi et al |
| https://pubmed.ncbi.nlm.nih.gov/35880298/ | Under-awareness and over-diagnosis of COVID-19 vaccine ‘allergy’ | Chiang V et al |
| https://pubmed.ncbi.nlm.nih.gov/35875513/ | Pityriasis lichenoides chronica induced by COVID-19 messenger RNA vaccination | Muqrin et al |
| https://pubmed.ncbi.nlm.nih.gov/35855232/ | Psoriasis Flares in Patients With COVID-19 Infection or Vaccination: A Case Series | Shah & Busquets |
| https://pubmed.ncbi.nlm.nih.gov/35851250/ | Oral lichen planus arising after BNT162b2 mRNA COVID-19 vaccine: report of 2 cases | Raccampo et al |
| https://pubmed.ncbi.nlm.nih.gov/35850789/ | Transient cryoglobulinaemic vasculitis following ChAdOx1 nCoV-19 vaccine | Ahmer et al |
| https://pubmed.ncbi.nlm.nih.gov/35850104/ | ANCA-Associated Vasculitis following the First Dose of Pfizer-BioNTech COVID-19 Vaccine | Hasbani & Uthman |
| https://pubmed.ncbi.nlm.nih.gov/35845348/ | New-onset pemphigus vegetans and pemphigus foliaceus after SARS-CoV-2 vaccination: A report of 2 cases | Gui H et al |
| https://pubmed.ncbi.nlm.nih.gov/35835178/ | Gianotti-Crosti Syndrome of Atypical Location in an Adult Following SARS-CoV-2 Vaccination | Pestana et al |
| https://pubmed.ncbi.nlm.nih.gov/35832214/ | ANCA-associated vasculitis following Johnson and Johnson COVID-19 vaccine | Yadav et al |
| https://pubmed.ncbi.nlm.nih.gov/35812079/ | Acute vulvar ulcers and the COVID-19 booster vaccine | Salusti-Simpson et al |
| https://pubmed.ncbi.nlm.nih.gov/35811413/ | Generalized morphea following the COVID vaccine: A series of two patients and a bibliographic review | Antoñanzas et al |
| https://pubmed.ncbi.nlm.nih.gov/35789676/ | Blaschkolinear acquired inflammatory skin eruption (blaschkitis) following COVID-19 vaccination | Rovira-López & Pujol |
| https://pubmed.ncbi.nlm.nih.gov/35756074/ | Vitiligo of the arm after COVID-19 vaccination | Singh R et al |
| https://pubmed.ncbi.nlm.nih.gov/36185929/ | Relapse of Palmoplantar Pustulosis Following COVID-19 Vaccination | Katsuie et al |
| https://pubmed.ncbi.nlm.nih.gov/36183151/ | Lichen planus pigmentosus post COVID-19-vaccination | Chaima et al |
| https://pubmed.ncbi.nlm.nih.gov/36182117/ | Livedo reticularis after COVID-19 vaccination | Horino et al |
| https://pubmed.ncbi.nlm.nih.gov/36164291/ | New-Onset Lichen Planus Induced by the Pfizer COVID-19 Vaccine | Alghamdi et al |
| https://pubmed.ncbi.nlm.nih.gov/36136900/ | Livedoid skin reaction to 2nd dose of mRNA Covid-19 vaccine | Girolami et al |
| https://pubmed.ncbi.nlm.nih.gov/36219526/ | Atypical presentation of Sweet syndrome with nodular erythema and oral ulcerations provoked by Ad26.COV2.S SARS-CoV-2 vaccination and review of literature | Bechtold & Owczarczyk-Saczonek |
| https://pubmed.ncbi.nlm.nih.gov/36125778/ | Asymmetric Periflexural Exanthem in an Adult Patient After Pfizer-BioNTech COVID-19 Vaccine | Thabouti et al |
| https://pubmed.ncbi.nlm.nih.gov/36259862/’ | A new eruption of bullous pemphigoid following mRNA COVID-19 vaccination | Daines et al |
| https://pubmed.ncbi.nlm.nih.gov/36340858/ | Cutaneous lupus erythematosus flare with vitiligo-like depigmentation following the AstraZeneca COVID vaccine | Bakr et al |
| https://pubmed.ncbi.nlm.nih.gov/36340561/ | A Patient Develops Bullous Rash After Receiving the Second Dose of COVID-19 Vaccine | Nida SS et al |
| https://pubmed.ncbi.nlm.nih.gov/36314709/ | A Histologic Timeline of a Delayed Hypersensitivity Reaction after the COVID-19 Pfizer Booster | Strong HA et al |
| https://pubmed.ncbi.nlm.nih.gov/36304618/ | Erythema multiforme after third COVID-19 vaccination (Pfizer-BioNTech) | Batta et al |
| https://pubmed.ncbi.nlm.nih.gov/36302245/ | Severe cutaneous reaction to the messenger RNA (mRNA) BNT162b2 (Pfizer-BioNTech) vaccine | Sapsford & Wood |
| https://pubmed.ncbi.nlm.nih.gov/36298511/ | Vitiligo-like Lesions and COVID-19: Case Report and Review of Vaccination- and Infection-Associated Vitiligo | Macca et al |
| https://pubmed.ncbi.nlm.nih.gov/35595719/ | New onset and exacerbation of oral lichenoid mucositis following SARS-CoV-2 infection or vaccination | Alabdulaaly et al |
| https://pubmed.ncbi.nlm.nih.gov/35560571/ | Flare-up of generalized pustular psoriasis following Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine: Two cases without mutations of IL36RN and CARD14 genes | Tachibana et al |
| https://pubmed.ncbi.nlm.nih.gov/34897817/ | Development of pemphigus vulgaris following mRNA SARS-CoV-19 BNT162b2 vaccination in an 89-year-old patient | Knechtl et al |
| https://pubmed.ncbi.nlm.nih.gov/36592149/ | Tozinameran (Pfizer-BioNTech COVID-19 vaccine)-induced AGEP-DRESS syndrome | Tay WC et al |
| https://pubmed.ncbi.nlm.nih.gov/36592047/ | mRNA-1273 COVID-19 vaccine-induced Steven-Johnson syndrome | Lo HK et al |
| https://pubmed.ncbi.nlm.nih.gov/36591352/ | Rash, Abdominal Pain, Proteinuria, and AKI after COVID-19 Vaccination | Lazoff et al |
| https://pubmed.ncbi.nlm.nih.gov/36590078/ | An asymmetric morbilliform eruption in an adult male | Yelich et al |
| https://pubmed.ncbi.nlm.nih.gov/36562098/ | A rare presentation of rapidly progressing myopathy in an adolescent | Pepys et al |
| https://pubmed.ncbi.nlm.nih.gov/36540524/ | A Case Report of Exfoliative Bullous Rash Following AstraZeneca Vaccine | Saleem & Goh |
| https://pubmed.ncbi.nlm.nih.gov/36531266/ | Lipschütz ulceration in a 12-year-old girl following second dose of Comirnaty (Pfizer) COVID-19 vaccine | Frederiks et al |
| https://pubmed.ncbi.nlm.nih.gov/36514459/ | Generalized fixed drug eruption following Pfizer-BioNtech COVID-19 vaccination | Kabir S et al |
| https://pubmed.ncbi.nlm.nih.gov/36504544/ | Multiple Keratoacanthomas Following Moderna Messenger RNA-1273 COVID-19 Vaccination Resolved With 5-Fluorouracil Treatment: Case Report | Ahmed F et al |
| https://pubmed.ncbi.nlm.nih.gov/36503530/ | Systemic drug-related intertriginous and flexural exanthema-like eruption after Oxford-AstraZeneca COVID-19 vaccine | Di Bona et al |
| https://pubmed.ncbi.nlm.nih.gov/36466142/ | Localized eczematous rash affecting left and right regions of breast and shoulder after Ad26.COV2.S vaccine against COVID-19 in a 30-year-old woman with comorbidities | Anasiewicz et al |
| https://pubmed.ncbi.nlm.nih.gov/36451671/ | Livedo reticularis following administration of ChAdOx1 nCoV-19 vaccine (AZD1222): a report of two cases | Kim JH et al |
| https://pubmed.ncbi.nlm.nih.gov/36451284/ | Erythema nodosum after COVID-19 vaccine: Report of two pediatric cases | Gonzalez-Canete et al |
| https://pubmed.ncbi.nlm.nih.gov/36448713/ | Systemic lupus erythematosus with acrocyanosis after AstraZeneca COVID-19 vaccination | Wang HJ et al |
| https://pubmed.ncbi.nlm.nih.gov/36426538/ | Pyoderma Gangrenosum Triggered by COVID-19 Vaccination in a Patient with Ulcerative Colitis: A Case Report | Kim YC et al |
| https://pubmed.ncbi.nlm.nih.gov/36423067/ | A Case of Purpura Annularis Telangiectodes of Majocchi after Anti-SARS-CoV-2 Pfizer-BioNTech Vaccine: Is There an Association? | Ambrogio et al |
| https://pubmed.ncbi.nlm.nih.gov/36406337/ | Resolution of recalcitrant verruca following Moderna COVID-19 vaccination in a person with HIV | Bressler et al |
| https://pubmed.ncbi.nlm.nih.gov/36647894/ | An impressive case of alopecia universalis after COVID-19 vaccination: a coincidental finding or a consequence? | Peterle et al |
| https://pubmed.ncbi.nlm.nih.gov/36638370/ | Psoriasiform Dermatitis Associated With the Moderna COVID-19 Messenger RNA Vaccine | Daneshbod et al |
| https://pubmed.ncbi.nlm.nih.gov/36626570/ | Pityriasis Rubra Pilaris After Moderna COVID-19 Vaccination: A Case Report and Literature Review | Liu Ya et al |
| https://pubmed.ncbi.nlm.nih.gov/36624889/ | A Rare Cutaneous Manifestation: Leukocytoclastic Vasculitis after Pfizer-BioNTech COVID-19 Vaccination | Gomez YS et al |
| https://pubmed.ncbi.nlm.nih.gov/36683345/ | Cutaneous adverse reaction following COVID-19 vaccination: Report from a southern Italian referral centre. Comment on «cutaneous adverse reactions following the Pfizer/BioNTech COVID-19 vaccine» by Luo et al | Martora et al |
| https://pubmed.ncbi.nlm.nih.gov/35170477/ | Acantholytic Dyskeratosis Post-COVID Vaccination | Yang K et al |
| https://pubmed.ncbi.nlm.nih.gov/36514624/ | COVID-19 Vaccine: A Common Suspect but Rare Culprit in Drug Rash With Eosinophilia and Systemic Symptoms (DRESS) Syndrome | Hanna & Yang |
| https://pubmed.ncbi.nlm.nih.gov/36057958/ | Erythema multiforme following vaccination for SARS-CoV-2: Report of a case and review of the literature – Secondary Publication | Kobyashi Y et al |
| https://pubmed.ncbi.nlm.nih.gov/34821413/ | Case of atypical erythema multiforme following coronavirus disease 2019 vaccination | Iwasawa et al (2) |
| https://pubmed.ncbi.nlm.nih.gov/34865149/ | Erythema multiforme after SARS-CoV-2 messenger RNA vaccination | *NO AUTHOR* |
| https://pubmed.ncbi.nlm.nih.gov/34547145/ | Nevocentric erythema multiforme after SARS-COV-2 vaccine | Scharf C et al |
| https://pubmed.ncbi.nlm.nih.gov/34667612/ | Erythema Multiforme Major following SARS-CoV-2 vaccine | Saibene et al |
| https://pubmed.ncbi.nlm.nih.gov/35492355/ | Case Report: Idiopathic Subcutaneous Thrombotic Vasculopathy | Godbe et al |
| https://pubmed.ncbi.nlm.nih.gov/35441091/ | Eyelid erythema after coronavirus vaccination | Bárcena-Dahl et al |
| https://pubmed.ncbi.nlm.nih.gov/35652448/ | Urticarial vasculitis after COVID-19 vaccination: A case report and literature review | Ono et al |
| https://pubmed.ncbi.nlm.nih.gov/36511288/ | Exacerbation of Chronic Cutaneous Lupus Erythematosus Triggered by Vaccine Against COVID-19 | Souza EN et al |
| https://pubmed.ncbi.nlm.nih.gov/36246778/ | New diagnosis of systemic lupus erythematosus after COVID-19 vaccination: A case report and review of literature | Khanna et al |
| https://pubmed.ncbi.nlm.nih.gov/34529877/ | Cutaneous small-vessel vasculitis following COVID-19 vaccine | Kar BR et al |
| https://pubmed.ncbi.nlm.nih.gov/35690533/ | A Case of Leukocytoclastic Vasculitis Following SARS-COV-2 Vaccination | Ball-Burack & Kosowsky |
| https://pubmed.ncbi.nlm.nih.gov/36146490/ | Delayed Skin Reactions to COVID-19 mRNA-1273 Vaccine: Case Report and Literature Review | Wang RL et al |
| https://pubmed.ncbi.nlm.nih.gov/35818815/ | Symptomatic hyponatremia after ChAdOx1 nCoV-19 coronavirus disease-19 vaccination | Chienwichai et al |
